Jan 9, 2015

Judge delivers blow to maker of Alzheimer's drug Namenda

This 2 minute video frames the issue surrounding drug maker Actavis' attempt to force Alzheimer's patients to buy a much more expensive version of the drug Namenda.

This video is worth watching and sharing with everyone you know in the Alzheimer's community.

Judge delivers blow to maker of Alzheimer's drug Namenda

By Bob DeMarco
Alzheimer's Reading Room

A judge has forced Actavis to continue selling 10 mg Namenda inspite of their attempt to take it off the market and switch to the more expensive version of the drug Namenda XR.

The 10 mg version of Namenda is scheduled to become generic in July, 2015. Shortly thereafter the drug is expected to fall in price by 70-80 percent.

We were paying more than $250 a month when Aricept went generic. You can now purchase a year supply of the drug for just over $100.

Subscribe to the Alzheimer's Reading - This is a Free Service - Join Now

Also see.

Will a cure for Alzheimer's ever be found?

Court to give speedy answer in Actavis bid to yank old Namenda off market

You are reading original content the Alzheimer's Reading Room

Learn More

What is the Difference Between Alzheimer’s and Dementia

Test Your Memory for Alzheimer's and Dementia (5 Best Tests)

Dementia Patients are People Too

Communicating in Alzheimer's World

What is Alzheimer's Disease?

The Last 25 Articles in the Alzheimer's Reading Room